Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

BCL2 overexpression associated with chromosomal amplification in diffuse large B-cell lymphoma

O Monni1, H Joensuu, K Franssila

  • 1Department of Medical Genetics, Haartman Institute, University of Helsinki, Finland.

Blood
|August 1, 1997
PubMed
Summary

Gene amplification of BCL2 is a key driver in diffuse large B-cell lymphoma, leading to overexpression of BCL2 protein. This contrasts with the known translocation mechanism, highlighting a novel pathway in lymphoma development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety, pharmacokinetics, pharmacodynamics, and antitumor activity of cergutuzumab amunaleukin: a phase I study in patients with advanced and/or metastatic solid tumors.

ESMO open·2026
Same author

Including tumor-infiltrating lymphocytes into the PREDICT prognostic model for triple-negative breast cancer survival.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up<sup>☆</sup>.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Benefit of pazopanib in advanced gastrointestinal stromal tumours: results from a phase II trial (SSG XXI, PAGIST).

ESMO open·2021

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Gene translocation to immunoglobulin heavy-chain genes activates oncogenes in B-cell lymphomas.
  • The role of oncogene amplification in non-Hodgkin's lymphomas remains poorly understood.

Purpose of the Study:

  • To investigate the significance of BCL2 gene amplification in diffuse large B-cell lymphoma (DLBCL).
  • To determine the correlation between BCL2 amplification, BCL2 protein expression, and translocation events in DLBCL.

Main Methods:

  • Utilized comparative genomic hybridization (CGH) and Southern blot hybridization to detect BCL2 gene amplification.
  • Employed Western blot analysis and immunohistochemistry to assess BCL2 protein levels.
  • Performed metaphase fluorescence in situ hybridization and chromosome analysis for cytogenetic evaluation.

Related Experiment Videos

Main Results:

  • BCL2 amplification was identified in 31% of DLBCL cases (8 out of 26) via CGH and Southern blot.
  • High-level BCL2 protein expression was observed in cases with BCL2 amplification and in those with t(14;18)(q32;q21) translocation.
  • Crucially, the t(14;18)(q32;q21) translocation was absent in all cases exhibiting BCL2 gene amplification.

Conclusions:

  • Gene amplification of BCL2 represents a significant mechanism for BCL2 protein overexpression in DLBCL.
  • This amplification pathway is distinct from the commonly observed t(14;18)(q32;q21) translocation.
  • Findings suggest BCL2 amplification is an important oncogenic event in the pathogenesis of DLBCL.